442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
First Industrial Realty Trust amended and restated its revolving credit facility, raising borrowing capacity from $750.0 million to $850.0 million and extending maturity to March 16, 2029. It also refinanced its $200.0 million unsecured term loan, extending its maturity to March 17, 2028, with lower pricing spreads and longer extension options. The changes add liquidity and push out debt maturities, though the filing reports no change to earnings or guidance.
Revolving facility increased from $750.0 million to $850.0 million, with an accordion feature to $1.0 billion
Revolver maturity extended from July 7, 2025 to March 16, 2029; term loan maturity extended from July 7, 2026 to March 17, 2028
Revolver had $431.0 million outstanding; applicable margin set at 0.775% based on BBB/Baa2/BBB ratings
Company has fully and unconditionally guaranteed borrowings under both agreements
ON Semiconductor disclosed that on March 17, 2025, management approved pre-tax non-cash impairment charges of between $600 million and $700 million on long-lived manufacturing equipment, as part of a restructuring plan announced February 24, 2025. The company says the charges will reduce 2025 depreciation expense by $30 million to $35 million and do not are expected to require material future cash spending, though actual amounts may differ.
Pre-tax non-cash impairment charges of between $600 million and $700 million approved March 17, 2025
Charges relate to manufacturing equipment at certain facilities, treated as held for sale
Estimated 2025 depreciation expense reduction of $30 million to $35 million
Most charges expected in the first two quarters of 2025
CSW Industrials agreed on March 17, 2025, to buy Aspen Manufacturing, a maker of evaporator coils and air handlers for the HVAC/R market, for a base price of $313.5 million in cash, subject to customary adjustments. The filing says the deal will be funded with cash on hand and debt under the company's existing $500 million credit facility, and closing is expected in the first quarter of CSWI's 2026 fiscal year, subject to closing conditions including the Hart-Scott-Rodino waiting period.
Base purchase price of $313.5 million in cash, with $8 million placed in escrow to secure post-closing adjustments and indemnities
Company cites an purchase price of about 11x Aspen's estimated 2024 adjusted EBITDA of $28.5 million
Aspen's estimated 2024 revenues were $122.4 million; the merger agreement can be terminated if closing has not occurred by September 17, 2025
Closing is not subject to a financing condition; the company expects the deal to be immediately accretive to EPS and EBITDA
HealthEquity reported fiscal 2025 results for the year ended January 31, 2025, with revenue of $1.20 billion (up 20%) and GAAP net income of $96.7 million, or $1.09 per diluted share, up from $55.7 million, or $0.64, a year earlier. Fourth-quarter net income was flat at $26.4 million, while the company guided to fiscal 2026 revenue of $1.280 billion to $1.305 billion and GAAP net income per diluted share of $1.85 to $2.01.
Fiscal 2025 revenue of $1.20 billion, up 20% from $999.6 million; Adjusted EBITDA of $471.8 million, up 28%.
Fourth-quarter revenue of $311.8 million, up 19%; net income of $26.4 million, unchanged from the prior-year quarter.
Fiscal 2026 outlook: revenue of $1.280 billion to $1.305 billion; GAAP net income per diluted share of $1.85 to $2.01; Adjusted EBITDA of $525 million to $545 million.
Completed the BenefitWallet HSA portfolio acquisition for a purchase price of $425.0 million and repurchased 1.4 million shares for $122.2 million during the year.
Cummins said Chief Administrative Officer Sharon Barner will retire effective May 31, 2025, after 13 years with the company. The company has not yet named a replacement, which it said will happen in the coming weeks.
Sharon Barner, Chief Administrative Officer, retires effective May 31, 2025
Barner joined Cummins in 2012 and became Chief Administrative Officer in 2021
Replacement to be named in the coming weeks, per the press release
Liquidia Technologies, a wholly owned subsidiary of Liquidia Corporation, signed a Sixth Amendment to its Revenue Interest Financing Agreement with HealthCare Royalty Partners IV on March 17, 2025, adding up to $100 million in financing in three tranches. The company received $25.0 million at the effective date, with the remaining tranches tied to YUTREPIA commercial milestones. Repayments are capped at 175% of amounts advanced and follow a fixed schedule ending in 2032, so the added funding comes with a defined repayment obligation.
$25.0 million funded on the March 17, 2025 effective date
$50.0 million to be funded after the first commercial sale of YUTREPIA following final FDA approval for PAH and PH-ILD, absent an injunction
$25.0 million to be funded by mutual agreement if aggregate YUTREPIA net sales exceed $100 million on or before June 30, 2026
Aggregate payments capped at 175% of amounts advanced; fixed payment schedule terminates in 2032
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.